University of California Irvine Medical Center

Orange, CA
(888) 850-0650

Sorting 1 by

Accepting patients

LINKER-MM4

Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma
Learn more
  • Bispecific Antibody
  • BCMA
  • Phase 1/2